Azithromycin versus placebo for the treatment of HIV-associated chronic lung disease in children and adolescents (BREATHE trial): study protocol for a randomised controlled trial.

Gonzalez-Martinez, C; Kranzer, K; McHugh, G; Corbett, EL; Mujuru, H; Nicol, MP; Rowland-Jones, S; Rehman, AM; Gutteberg, TJ; Flaegstad, T; +18 more... Odland, JO; Ferrand, RA; BREATHE study team; , COLLABORATORS; Bandason, T; Cavanagh, P; Dauya, E; Majonga, E; Makamure, B; Mapurisa, GN; Mbhele, S; Moyo, BW; Ngwira, LG; Rylance, J; Simms, V; Sovershaeva, E; Weiss, HA; Yindom, LM; (2017) Azithromycin versus placebo for the treatment of HIV-associated chronic lung disease in children and adolescents (BREATHE trial): study protocol for a randomised controlled trial. Trials, 18 (1). p. 622. ISSN 1745-6215 DOI: https://doi.org/10.1186/s13063-017-2344-2

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1186/s13063-017-2344-2

Abstract

Share

Download

Filename: Azithromycin versus placebo for the treatment of HIV-associated chronic lung disease in children and adolescents_GOLD VoR.pdf

Licence: Creative Commons: Attribution 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar